Literature DB >> 2558849

An improved model of recurrent herpetic eye disease in mice.

C Shimeld1, T Hill, B Blyth, D Easty.   

Abstract

Mice were passively immunized with serum containing antibodies to herpes simplex virus type 1 (HSV-1) before inoculation on the cornea with HSV-1 strain McKrae. After such immunization most mice survived and most had normal eyes. When primary infection had subsided, mice with normal eyes were selected and treated with cyclophosphamide, dexamethasone and UV irradiation of the inoculated eye or UV irradiation alone, to reactivate latent virus. After either treatment mice developed signs of recurrent infection (virus in eyewashings and recurrent corneal and/or lid disease). The incidence of such signs was 17/33 (52%) in mice receiving immunosuppressive drugs and UV irradiation and 19/32 (59%) in mice given UV irradiation alone. In mice treated with either stimulus dendritic or geographic ulceration of the cornea was seen. These closely resembled the herpetic lesions seen in humans. There was good correlation between the pattern and distribution of recurrent corneal disease and the distribution of cells containing virus antigens in corneal epithelial sheets. Again, as in humans, the induction of recurrent infection was found to correlate poorly with a rise in the level of serum neutralizing antibody. In mice treated with UV irradiation alone corneal ulcers healed and the eyes returned to normal. By contrast, in mice given immunosuppressive drugs and UV irradiation, the ulceration became more severe and the eyes became opaque and vascularized. The use of passive immunization has greatly improved our previously reported model of recurrent herpetic eye disease since it has increased the incidence of mice suitable for the induction of recurrent infection and has increased the incidence of such infection.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2558849     DOI: 10.3109/02713688909000044

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  20 in total

1.  Comparison of herpes simplex virus reactivation in ganglia in vivo and in explants demonstrates quantitative and qualitative differences.

Authors:  N M Sawtell; R L Thompson
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

2.  Decreased reactivation of a herpes simplex virus type 1 (HSV-1) latency-associated transcript (LAT) mutant using the in vivo mouse UV-B model of induced reactivation.

Authors:  Lbachir BenMohamed; Nelson Osorio; Ruchi Srivastava; Arif A Khan; Jennifer L Simpson; Steven L Wechsler
Journal:  J Neurovirol       Date:  2015-05-22       Impact factor: 2.643

3.  Recurrent herpetic stromal keratitis in mice, a model for studying human HSK.

Authors:  Jessica Morris; Patrick M Stuart; Megan Rogge; Chloe Potter; Nipun Gupta; Xiao-Tang Yin
Journal:  J Vis Exp       Date:  2012-12-18       Impact factor: 1.355

4.  Mechanisms of herpes simplex virus type 1 reactivation.

Authors:  W P Halford; B M Gebhardt; D J Carr
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

5.  Valacyclovir for the prevention of recurrent herpes simplex virus eye disease after excimer laser photokeratectomy.

Authors:  P A Asbell
Journal:  Trans Am Ophthalmol Soc       Date:  2000

6.  CD28 Costimulation Is Required for Development of Herpetic Stromal Keratitis but Does Not Prevent Establishment of Latency.

Authors:  Xiao-Tang Yin; Nicholas K Baugnon; Chloe A Potter; Shannon Tai; Tammie L Keadle; Patrick M Stuart
Journal:  J Virol       Date:  2019-07-30       Impact factor: 5.103

Review 7.  Potential function of miRNAs in herpetic stromal keratitis.

Authors:  Sachin Mulik; Siddheshvar Bhela; Barry T Rouse
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-01-17       Impact factor: 4.799

8.  The herpes simplex virus type 1 ICP0 promoter is activated by viral reactivation stimuli in trigeminal ganglia neurons of transgenic mice.

Authors:  C M Loiacono; N S Taus; W J Mitchell
Journal:  J Neurovirol       Date:  2003-06       Impact factor: 2.643

9.  Non-traumatic acquisition of herpes simplex virus infection through the eye.

Authors:  S B Kaye; C Shimeld; E Grinfeld; N J Maitland; T J Hill; D L Easty
Journal:  Br J Ophthalmol       Date:  1992-07       Impact factor: 4.638

10.  The role of nerve growth factor in modulating herpes simplex virus reactivation in vivo.

Authors:  K A Laycock; R H Brady; S F Lee; P A Osborne; E M Johnson; J S Pepose
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-07       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.